Using the Updated EWGSOP2 Definition in Diagnosing Sarcopenia in Spanish Older Adults: Clinical Approach

Recently the European Working Group on Sarcopenia in Older People (EWGSOP2) has updated diagnostic criteria for sarcopenia, which consist of one or more measures of muscle strength, muscle mass, and physical performance, plus an initial screening test called SARC-F. The main objective was to compare...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2021-03, Vol.10 (5), p.1018
Main Authors: Arnal-Gómez, Anna, Cebrià I Iranzo, Maria A, Tomas, Jose M, Tortosa-Chuliá, Maria A, Balasch-Bernat, Mercè, Sentandreu-Mañó, Trinidad, Forcano, Silvia, Cezón-Serrano, Natalia
Format: Article
Language:English
Subjects:
Algorithms
Clinical medicine
Edema
Gait
Institutionalization
Muscle strength
Musculoskeletal system
Older people
Questionnaires
Sarcopenia
Women
Working groups
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recently the European Working Group on Sarcopenia in Older People (EWGSOP2) has updated diagnostic criteria for sarcopenia, which consist of one or more measures of muscle strength, muscle mass, and physical performance, plus an initial screening test called SARC-F. The main objective was to compare the number of cases of sarcopenia, using the different measurements and screening options. A cross-sectional study was conducted on Spanish older adults ( = 272, 72% women). Combining the different measures proposed by the steps described in the EWGSOP2 algorithm, 12 options were obtained (A-L). These options were studied in each of the three models: (1) using SARC-F as initial screening; (2) not using SARC-F; and (3) using SARC-CalF instead of SARC-F. A χ independence test was statistically significant (χ (6) = 88.41, < 0.001), and the association between the algorithm used and the classification of sarcopenia was moderate (Cramer's V = 0.226). We conclude that the different EWGSOP2 measurement options imply case-finding differences in the studied population. Moreover, when applying the SARC-F, the number of people classified as sarcopenic decreases. Finally, when SARC-CalF is used as screening, case finding of sarcopenic people decreases. Thus, clinical settings should consider these outcomes, since these steps can make preventive and therapeutic interventions on sarcopenia vary widely.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm10051018